| MolName | (5Z)-3-cyclohexyl-5-[[2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C25H31N5O3S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(NCCCN3CCOCC3)N=C(C=CC=C3)N3C2=O)N(C2CCCCC2)C1=S |
| InChI | InChI=1S/C25H31N5O3S2/c31-23-19(17-20-24(32)30(25(34)35-20)18-7-2-1-3-8-18)22(27-21-9-4-5-12-29(21)23)26-10-6-11-28-13-15-33-16-14-28/h4-5,9,12,17-18,26H,1-3,6-8,10-11,13-16H2 |
| InChIK | MADZVPDLFYXCAQ-UHFFFAOYSA-N |
| TotalMolweight | 513.685 |
| Molweight | 513.685 |
| MonoisotopicMass | 513.18683 |
| CLogP | 0.9437 |
| CLogS | -4.786 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 385.28 |
| Relative PSA | 0.29898 |
| PolarSurfaceArea | 134.87 |
| Druglikeness | 0.55148 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.51429 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 17 |
| Symmetricatoms | 4 |
| Amides | 2 |
| Amines | 1 |
| AlkylAmines | 1 |
| BasicNitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (5Z)-3-cyclohexyl-5-[[2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-cyclohexyl-5-[[2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one